Prof. Maria Paola Martelli, PI, was awarded access to European high-end facilities and service providers free of charge within the 2nd Corbel Call, a project that receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 654248.
The CORBEL will support the project titled ‘High-throughput compound screening approach to identify drugs targeting the acute myeloid leukemia (AML) entity harbouring NPM1 gene mutation’.
The new research infrastructures partners in the PI’s project are the EU-OPENSCREEN, Screening Unit and Medicinal Chemistry group, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, FMP and the Advanced Light Microscopy at EMBL, Heidelberg.